Increased atrial natriuretic peptide in the nephrotic syndrome. Relationship to the renal function and the renin-angiotensin-aldosterone system

References

• De Bold A J, Borenstein H B, Veress A T, Sonneberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Atlas S A, Kleinert H D, Camargo M J, Januszewicz A, Sealey J E, Laragh J H, Schilling J N, Lewicki J A, Johnson L K, Maack T. Purification sequencing and synthesis of natriuretic and vasoactive rate atrial peptide. Nature 1984; 309: 717–9
   PubMed Web of Science ®Google Scholar
• Garcia R, Thibault G, Cantin M, Genest J. Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds. Am J Physiol 1984; 247: R34–9
   PubMed Web of Science ®Google Scholar
• Richards A M, Nicholls M G, Ikram H, Webster M WI, Yandle T G, Espiner E A. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1985; I: 545–9
   Google Scholar
• Sagnella G A, Markandu N D, Shore A C, Mac-Gregor G A. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet 1985; II: 1208–10
   Google Scholar
• Anderson J, Struthers A, Christofides N, Bloom S. Atrial natriuretic peptide: an endogenous factor enhancing sodium excretion in man. Clin Sci 1986; 70: 327–31
   PubMed Web of Science ®Google Scholar
• Weidmann P, Hasler L, Gnädinger MP, Lang R E, Uehlinger D E, Shaw S, Rascher W, Reubi F C. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734–42
   PubMed Web of Science ®Google Scholar
• Nakaoka I I, Imataka K, Amano M, Fujii J, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 1985; 313: 892–3
   PubMed Web of Science ®Google Scholar
• Tikkanen I, Fyhrquist F, Metsärinne K, Leidenius R. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet 1985; II: 66–9
   Google Scholar
• Espiner E A, Crozier I G, Nicholls M G, Cuneo R, Yandle T G, Ikram H. Cardiac secretion of atrial natriuretic peptide. Lancet 1985; II: 398–9
   Google Scholar
• Ogawa K, Ito T, Hashimoto H, Ito Y, Ohno O, Tsuboi H, Takasu N, Tanahashi T, Satake T. Plasma atrial natriuretic factor in congestive heart failure. Lancet 1986; I: 106
   Google Scholar
• Shenker Y, Sider R S, Ostafin E A, Grekin R J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985; 76: 1684–7
   PubMed Web of Science ®Google Scholar
• Fernandez-Cruz A, Marco J, Cuadrado L M, Gutkowska J, Rodriguez-Puyol D, Caramelo C, Lopez-Novoa J M. Plasma levels of atrial natriuretic peptide in cirrhotic patients. Lancet 1985; II: 1439–40
   Google Scholar
• Churg J. Renal Disease, Classification and Atlas of Glomerular Disease. Igahu-Shoin, Tokyo 1982
   Google Scholar
• Thomassen A, Bagger J P, Nielsen X T, Pedersen E B. Atrial natriuretic peptide during pacing in controls and patients with coronary artery disease. Int J Cardiol 1987, in press
   PubMed Web of Science ®Google Scholar
• Kappelgaard A M, Damkjaer Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976; 67: 299–306
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J, Bruusgaard A, Munck O, Nielsen M D, Worming H. The significance of bile acids and aldosterone for the electrical hyper-polarisation of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1974; 9: 417–26
   PubMed Web of Science ®Google Scholar
• Bradley J V. Distribution-Free Statistical Tests. Prentice Hall, New Jersey 1968
   Google Scholar
• Tulassay T, Rascher W., Lang R E, Seyberth H W, Schärer K. Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. Kidney Int 1987; 31: 1391–5
   PubMed Web of Science ®Google Scholar
• Sonnenberg H. Atrial natriuretic factor—a new hormone affecting kidney function. Klin Wochenschr 1985; 63: 886–90
   PubMedGoogle Scholar
• Ballennann B J, Brenner B M. Role of atrial peptides in hody fluid homeostasis. Circ Res 1986; 58: 619–30
   PubMed Web of Science ®Google Scholar
• Pedersen E B, Danielsen H, Madsen M, Jensen T. Defective renal water excretion in nephrotic syndrome: the relationship between renal water excretion and kidney function, arginine vasopressin, angiotensin II and aldosterone in plasma before and after oral water loading. Eur J Clin Invest 1985; 15: 24–9
   PubMed Web of Science ®Google Scholar
• Danielsen H, Pedersen E B, Madsen M, Jensen T. Abnormal venal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate. Acta Med Scand 1985; 217: 513–8
   PubMedGoogle Scholar
• Pedersen E B, Danielsen H, Sørensen S S, Jespersen B. Renal water excretion before and after remission of nephrotic syndrome: relationship between free water clearance and kidney function, arginine vasopressin, angiotensin II and aldosterone in plasma before and after oral water loading. Clin Sci 1986; 71: 97–104
   Web of Science ®Google Scholar
• Laragh J H. Atrial natriuretic hormone the renin-aldosterone axis and blood pressure-electrolyte homeostasis. N Engl J Med 1985; 313: 1330–40
   PubMed Web of Science ®Google Scholar
• Davis J O, Freeman R H. Mechanisms regulating renin release. Physiol Rev 1976; 56: 1–56
   PubMed Web of Science ®Google Scholar
• Maack T, Marion D N, Camargo M JF, Kleinert H D, Laragh J H, Vaughan E D, Jr., Atlas S A. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 1984; 77: 1069–75
   PubMed Web of Science ®Google Scholar
• Burnett C, Jr., Granger J P, Opgenorth T J. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984; 247: F863–6
   PubMed Web of Science ®Google Scholar
• Cody R J, Covit A B, Laragh J H, Atlas S A. Atrial natriuretic factors (ANF) in normal men: renal hemodynamic/hormonal responses. Hypertension 1985; 7: 845–52
   Web of Science ®Google Scholar
• Goodfriend T L, Elliott M E, Atlas S A. Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. Life Sci 1984; 35: 1675–82
   PubMed Web of Science ®Google Scholar
• Kudo T, Baird A. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature 1984; 312: 756–7
   PubMed Web of Science ®Google Scholar
• Atarashi K, Muliow P J, Franco-Saenz R. Effect of atrial peptides on aldosterone production. J Clin Invest 1985; 76: 1807–11
   PubMed Web of Science ®Google Scholar
• Kleinert H D, Maack T, Atlas S A, Januszewicz A, Sealey J E, Laragh J H. Atrial natriuretic factor inhibits angiotensin, norepinephrine-, and potassium-induced vascular contractility. Hypertension 1984; 6: 1143–7
   Web of Science ®Google Scholar
• Chartier L, Schiffrin E, Thibault G, Garcia R. Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo. Endocrinology 1984; 115: 2026–8
   PubMed Web of Science ®Google Scholar
• Anderson J V, Struthers A B, Payne N N, Slater J DH, Bloom S R. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin Sci 1986; 70: 507–12
   PubMed Web of Science ®Google Scholar
• Rascher W, Tulassay T, Lang R E. Atrial natriuretic peptide in plasma of volume overloaded children with chronic renal failure. Lancet 1985; II: 303–5
   Google Scholar
• Wilkins M R, Wood J A, Adu D, Lote C J, Kendall M J, Michael J. Changes in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci 1986; 71: 157–60
   Web of Science ®Google Scholar
• Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab 1986; 63: 819–22
   PubMed Web of Science ®Google Scholar
• Eiskjaer H E, Pedersen E B, Rasmussen L M, Jespersen B. Verapamil sustained release in renal hypertension. Effect on 24-hour ambulatory blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide and lipoproteins. Eur J Clin Pharmacol 1988, in press
   PubMedGoogle Scholar